Suvoda

Suvoda is a global clinical trial technology company founded in 2013 and based in the United States. The company provides IRT, eConsent, and eCOA software and services for complex, life-sustaining studies in therapeutic areas such as oncology, central nervous system, and rare disease. Their slogan, "IRT, eConsent, and eCOA solutions to help you wisely guide novel science through complex clinical trials," reflects their commitment to facilitating the advancement of innovative science in the pharmaceutical industry. In their last investment round in December 2019, Suvoda secured a significant $40.00M Venture Round investment from Ira Lubert. This investment demonstrates confidence in Suvoda's capabilities and potential for growth within the clinical trial technology sector. Suvoda's focus on addressing the complexities of clinical trials in critical therapeutic areas, coupled with their recent substantial investment, positions them as a noteworthy player in the pharmaceutical industry with the potential for further expansion and impact.